WEBCAST

COVID-19 Disruption in Life Sciences: Tax, Trade and Value Chain Implications

Webcast overview

As uncertainty about the economic impact of COVID-19 persists, the disruption is taking a toll on business supply chains and operations.  What is the impact to the life sciences industry? Join us for an interactive discussion of tax and trade implications including the following:

  • The implications of fluctuating production capacity and constrained resources
  • Federal and international tax issues related to process and innovation R&D, changing asset value, inventory, increased capital needs, and potential losses
  • Latest trade & customs landscape in the US as would affect Life Sciences, and potential developments on the horizon

Contact Walter Jaremczuk, U.S. International Corridors CMO, KPMG LLP (wjaremczuk@kpmg.com) with any questions.

Featured speakers

Christine Kachinsky

Christine Kachinsky

Partner, Tax, KPMG US

Steven Davis

Steven Davis

Principal, International Tax, Value Management, KPMG US

Kimberly Majure

Kimberly Majure

Principal, International Tax, KPMG US

Martin Mazin

Martin Mazin

Partner, Economic & Valuation Services, KPMG US

Scott Vance

Scott Vance

Principal, Tax, KPMG US

Chris Young

Chris Young

Principal, Trade and Customs Services, KPMG US

Prita Subramanian

Prita Subramanian

Principal, Economic & Valuation Services, KPMG US

Related content